CD56/NCAM mediates cell migration of human NK cells by promoting integrin-mediated adhesion turnover. | CD56/NCAM mediates cell migration of human NK cells by promoting integrin-mediated adhesion turnover. Martinez AL, Shannon MJ, Sloan T, Mace EM., Free PMC Article | 04/19/2024 |
Expression and Clinical Significance of CD30 and CD56 in Lymphoblastic Lymphoma: A Retrospective Analysis on Paraffin-Embedded Tissues by Immunohistochemistry. | Expression and Clinical Significance of CD30 and CD56 in Lymphoblastic Lymphoma: A Retrospective Analysis on Paraffin-Embedded Tissues by Immunohistochemistry. Li S, Zheng S, Huang X, Zhang W, Liu F, Cao Q. | 04/17/2024 |
Plasma-derived extracellular vesicle surface markers CD45, CD326 and CD56 correlate with the stage of osteoarthritis: a primary study of a novel and promising diagnostic tool of the disease. | Plasma-derived extracellular vesicle surface markers CD45, CD326 and CD56 correlate with the stage of osteoarthritis: a primary study of a novel and promising diagnostic tool of the disease. Matejova J, Fecskeova LK, Slovinska L, Harvanova D, Spakova T, Bzdilova J., Free PMC Article | 11/28/2023 |
A Comparative Study of CD56 and Smooth Muscle Actin Expression in Basal and Squamous Cell Carcinomas. | A Comparative Study of CD56 and Smooth Muscle Actin Expression in Basal and Squamous Cell Carcinomas. Yirmibes S, Balaban Adim S. | 11/22/2023 |
Investigation of CD56, ADAM17 and FGF21 Expressions in the Placentas of Preeclampsia Cases. | Investigation of CD56, ADAM17 and FGF21 Expressions in the Placentas of Preeclampsia Cases. Darka Aslan I, Sel G, Barut F, Baser Acikgoz R, Balci S, Ozmen U, Barut A, Harma M, Harma MI., Free PMC Article | 07/7/2023 |
[Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors]. | [Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors]. Wang XX, Zhang LL, Wang T, Hou JX, Wang ZT, Qin H. | 06/29/2023 |
CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review. | CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review. Gasljevic G, Boltezar L, Novakovic S, Setrajcic-Dragos V, Jezersek-Novakovic B, Kloboves-Prevodnik V., Free PMC Article | 06/23/2023 |
Neural cell adhesion molecule 1 is a cellular target engaged plasma biomarker in demyelinating Charcot-Marie-Tooth disease. | Neural cell adhesion molecule 1 is a cellular target engaged plasma biomarker in demyelinating Charcot-Marie-Tooth disease. Kim YH, Yoon BA, Jo YR, Nam SH, Kim NH, Kim KH, Kim JK, Choi BO, Park HT. | 05/22/2023 |
Retrospective Analysis of the Expression of CD56 in Multiple Myeloma with Bone-Related Extramedullary Diseases. | Retrospective Analysis of the Expression of CD56 in Multiple Myeloma with Bone-Related Extramedullary Diseases. Chen Q, Zheng X, Lin Q, Chen J. | 03/10/2023 |
Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia. | Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia. Liang T, Peng Z, Li C, Huang J, Wang H, Bu C, Li J, Zheng Y, Feng X, Li H, Chen C., Free PMC Article | 01/28/2023 |
NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma. | NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma. Seymour F, Cavenagh JD, Mathews J, Gribben JG., Free PMC Article | 09/24/2022 |
Human NK cells responses are enhanced by CD56 engagement. | Human NK cells responses are enhanced by CD56 engagement. Picard LK, Claus M, Fasbender F, Watzl C. | 09/17/2022 |
Redefining CD56 as a Biomarker and Therapeutic Target in Multiple Myeloma. | Redefining CD56 as a Biomarker and Therapeutic Target in Multiple Myeloma. Cottini F, Rodriguez J, Hughes T, Sharma N, Guo L, Lozanski G, Liu B, Cocucci E, Yang Y, Benson D. | 07/16/2022 |
Clinical, genetic, and pathological characterization of GNE myopathy in China. | Clinical, genetic, and pathological characterization of GNE myopathy in China. Lv XQ, Xu L, Lin PF, Yan CZ. | 06/25/2022 |
Evaluation of the Prognostic Value of CD56 (140 kDa Isoform) Expression in Breast Cancer Tissues: an Eight-Year Retrospective Study. | Evaluation of the Prognostic Value of CD56 (140 kDa Isoform) Expression in Breast Cancer Tissues: an Eight-Year Retrospective Study. Niknam K, Safaei A, Ghaderi A., Free PMC Article | 06/11/2022 |
Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality. | Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality. Song W, Lin GN, Yu S, Zhao M. | 05/14/2022 |
A functional SNP rs895819 on pre-miR-27a is associated with bipolar disorder by targeting NCAM1. | A functional SNP rs895819 on pre-miR-27a is associated with bipolar disorder by targeting NCAM1. Yang Y, Lu W, Ning M, Zhou X, Wan X, Mi Q, Yang X, Zhang D, Zhang Y, Jiang B, He L, Liu J, Zou Y., Free PMC Article | 04/9/2022 |
The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours. | The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours. Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Grieve J, Dorward N, Mendoza N, Nair R, Muquit S, Grossman AB, Korbonits M. | 03/26/2022 |
Immune Dysfunctions of CD56(neg) NK Cells Are Associated With HIV-1 Disease Progression. | Immune Dysfunctions of CD56(neg) NK Cells Are Associated With HIV-1 Disease Progression. Cao WJ, Zhang XC, Wan LY, Li QY, Mu XY, Guo AL, Zhou MJ, Shen LL, Zhang C, Fan X, Jiao YM, Xu RN, Zhou CB, Yuan JH, Wang SQ, Wang FS, Song JW., Free PMC Article | 03/12/2022 |
The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma. | The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma. Murakami K, Kumata H, Miyagi S, Kamei T, Sasano H. | 02/12/2022 |
CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome. | CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome. Koumpis E, Tassi I, Malea T, Papathanasiou K, Papakonstantinou I, Serpanou A, Tsolas E, Kapsali E, Vassilakopoulos TP, Papoudou-Bai A, Hatzimichael E. | 02/5/2022 |
Decreased Serum NCAM Levels Associated with Cognitive Impairment in Vascular Dementia. | Decreased Serum NCAM Levels Associated with Cognitive Impairment in Vascular Dementia. Zhao J, Lu W, Li J, Liu L, Zhao X., Free PMC Article | 01/29/2022 |
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders. | Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders. Eijsbouts C, Zheng T, Kennedy NA, Bonfiglio F, Anderson CA, Moutsianas L, Holliday J, Shi J, Shringarpure S, 23andMe Research Team, Voda AI, Bellygenes Initiative, Farrugia G, Franke A, Hübenthal M, Abecasis G, Zawistowski M, Skogholt AH, Ness-Jensen E, Hveem K, Esko T, Teder-Laving M, Zhernakova A, Camilleri M, Boeckxstaens G, Whorwell PJ, Spiller R, McVean G, D'Amato M, Jostins L, Parkes M., Free PMC Article | 01/1/2022 |
An association study in the Taiwan Biobank elicits three novel candidates for cognitive aging in old adults: NCAM1, TTC12 and ZBTB20. | An association study in the Taiwan Biobank elicits three novel candidates for cognitive aging in old adults: NCAM1, TTC12 and ZBTB20. Lin E, Kuo PH, Lin WY, Liu YL, Yang AC, Tsai SJ., Free PMC Article | 12/11/2021 |
Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56. | Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56. Drexler B, Tzankov A, Martinez M, Baerlocher S, Passweg JR, Dirnhofer S, Tsakiris DA, Dirks J. | 12/4/2021 |